Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» After setback, Adaptimmune revamps T cell study
After setback, Adaptimmune revamps T cell study
After setback, Adaptimmune revamps T cell study
Submitted by
admin
on October 13, 2016 - 10:53am
Source:
BioPharma Dive
News Tags:
Adaptimmune
t cell therapy
NY-ESO SPEAR
ovarian cancer
Headline:
After setback, Adaptimmune revamps T cell study
Do Not Allow Advertisers to Use My Personal information
